The landscape of UBE2S in hepatocellular carcinoma: Prognostic significance, immuno-oncology feature and drug response[J]. Genes & Diseases, 2023,10(2).
Lipeng Qiu, Yue Wang, Zhihuan Li, et al. The landscape of UBE2S in hepatocellular carcinoma: Prognostic significance, immuno-oncology feature and drug response[J]. Genes & Diseases, 2023,10(2).
The landscape of UBE2S in hepatocellular carcinoma: Prognostic significance, immuno-oncology feature and drug response[J]. Genes & Diseases, 2023,10(2). DOI: 10.1016/j.gendis.2022.04.010.
Lipeng Qiu, Yue Wang, Zhihuan Li, et al. The landscape of UBE2S in hepatocellular carcinoma: Prognostic significance, immuno-oncology feature and drug response[J]. Genes & Diseases, 2023,10(2). DOI: 10.1016/j.gendis.2022.04.010.
The landscape of UBE2S in hepatocellular carcinoma: Prognostic significance, immuno-oncology feature and drug response